Sunday, May 04, 2025 1:10:47 PM
I'm curious which hour of the day they will announce the MHRA decision. Also, will the company consider where UK and European shareholders will fit into the plan of when to announce. London is at work by 4 a.m. Eastern Time since they are 5 hours ahead of us. (That's 9 a.m. here on ET).
The only possible overlapping of markets is in the morning. If they announce just before or at opening of the US markets, then the UK will have a few hours to trade the stock before their market closes. But MHRA could contact NWBO with the news at the end of their day, which would be about noon here on the East Coast. Would NWBO immediately release the news or would they need to contact the companies they have contracted with to get final signatures or other details finalized. We know they want to release a blitze of news and, according to their quarterlies, they seem to have lots of news. They may also want to release news at the opening of the stock exchange, but that might allow news to leak overnight.
Any thoughts?
The only possible overlapping of markets is in the morning. If they announce just before or at opening of the US markets, then the UK will have a few hours to trade the stock before their market closes. But MHRA could contact NWBO with the news at the end of their day, which would be about noon here on the East Coast. Would NWBO immediately release the news or would they need to contact the companies they have contracted with to get final signatures or other details finalized. We know they want to release a blitze of news and, according to their quarterlies, they seem to have lots of news. They may also want to release news at the opening of the stock exchange, but that might allow news to leak overnight.
Any thoughts?
Bullish
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
